Phenox HPC and Phenox flow modulation devices for the endovascular treatment of intracranial aneurysms: a systematic review and meta-analysis.

Cem Bilgin Yigit Can Senol Kobeissi Hassan Atakan Orscelik Sherief A Ghozy Alexander A Oliver Ramanathan D Kadirvel Brinjikji WDavid F Kallmes

Published in: Journal of neurointerventional surgery (2023)

Our findings indicate that Phenox HPC is equally as safe and effective as non-coated Phenox devices. Additionally, our results suggest that prasugrel monotherapy might effectively prevent ischemic complications in patients treated with Phenox HPC flow diverters.

Keyphrases

endovascular treatment
percutaneous coronary intervention
open label
risk factors
combination therapy
ischemia reperfusion injury
randomized controlled trial
clinical trial